JB Chemicals& Pharmaceuticals has dipped 5% to Rs 124 after reporting a net loss of Rs 6.5 crore for the third quarter ended December 31, 2013 (Q3FY14), mainly on account of one-time loss of Rs 65 crore due to revision of sale price of Russia-CIS OTC business undertaking. The company had posted a net profit of Rs 21.87 crore during the same period of previous fiscal.
Net sales of the company rose to Rs 234 crore during the third quarter, as against Rs 200 crore during the same period of previous fiscal, JB Chemicals & Pharmaceuticals Ltd said in a filing to the BSE.
Operating profit however, nearly double to Rs 37 crore from Rs 19 crore, due to higher sales coupled with favourable product mix, the company said.
The stock opened at Rs 126 and touched a low of Rs 119 on the BSE. A combined around 325,000 shares changed hands on the counter till 1000 hours on the BSE and NSE.
Net sales of the company rose to Rs 234 crore during the third quarter, as against Rs 200 crore during the same period of previous fiscal, JB Chemicals & Pharmaceuticals Ltd said in a filing to the BSE.
Operating profit however, nearly double to Rs 37 crore from Rs 19 crore, due to higher sales coupled with favourable product mix, the company said.
The stock opened at Rs 126 and touched a low of Rs 119 on the BSE. A combined around 325,000 shares changed hands on the counter till 1000 hours on the BSE and NSE.
